IMA FY 2022 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$67M

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$16M-49.6% YoY

Gross Profit

-$49M-311.8% margin

Operating Income

-$71M-454.0% margin

Net Income

-$69M-440.3% margin

EPS (Diluted)

$-1.90

Cash Flow

Operating Cash Flow

-$74M

Free Cash Flow

-$76M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$172M

Total Liabilities

$25M

Stockholders' Equity

$147M

Cash & Equivalents

$60M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$16M	$31M	-49.6%
Gross Profit	-$49M	-$16M	-202.1%
Operating Income	-$71M	-$34M	-107.7%
Net Income	-$69M	-$34M	-101.6%